Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zelapar for dopamine agonist complications in Parkinson's disease
NCT00443872Phase 4Completed
- Sponsor
- Parkinson's Disease and Movement Disorder Center of Boca Raton
- Start
- Mar 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selegiline in Parkinson's disease (PD), sponsored by Parkinson's Disease and Movement Disorder Center of Boca Raton. Started Mar 2007; status: completed.
02
Drugs
selegiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00443872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443872.